5'-iodoresiniferatoxin [Ligand Id: 4109] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL595069 (5-Iodoresiniferatoxin, 5-Iodo-Resiniferatoxin, Iodoresiniferatoxin)
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
TRPV1/Vanilloid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4794] [GtoPdb: 507] [UniProtKB: Q8NER1]
ChEMBL Displacement of [3H]RTX from human TRPV1 expressed in CHO cells B 7.93 pKi 11.8 nM Ki Eur J Med Chem (2013) 68: 233-243 [PMID:23981530]
ChEMBL Displacement of [3H]RTX from human TRPV1 expressed in CHO cells after 60 mins by liquid scintillation counting analysis B 7.93 pKi 11.8 nM Ki Bioorg Med Chem Lett (2014) 24: 382-385 [PMID:24321344]
ChEMBL Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of RTX-induced 45Ca2+ uptake after 20 mins by liquid scintillation counting analysis B 8.23 pKi 5.9 nM Ki Bioorg Med Chem Lett (2014) 24: 382-385 [PMID:24321344]
ChEMBL Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of capsaicin-stimulated Ca2+ uptake B 8.23 pKi 5.87 nM Ki Eur J Med Chem (2013) 68: 233-243 [PMID:23981530]
ChEMBL Antagonist activity at human TRPV1 expressed in HEK293 cells assessed as inhibition of intracellular calcium level F 5.4 pIC50 4000 nM IC50 Bioorg Med Chem Lett (2010) 20: 97-99 [PMID:19951840]
GtoPdb - - 8.4 pIC50 3.9 nM IC50
TRPV1/Vanilloid receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5102] [GtoPdb: 507] [UniProtKB: O35433]
ChEMBL Antagonist activity at rat TRPV1 receptor expressed in CHO cells assessed as calcium 45 uptake F 7.91 pKi 12.2 nM Ki J Med Chem (2008) 51: 57-67 [PMID:18072720]
ChEMBL Displacement of [3H]RTX from rat TRPV1 receptor expressed in CHO cells B 9.21 pKi 0.61 nM Ki J Med Chem (2008) 51: 57-67 [PMID:18072720]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]